Detailed information for compound 1633899

Basic information

Technical information
  • TDR Targets ID: 1633899
  • Name: N-[(2,3-dichlorophenyl)methylideneamino]benze nesulfonamide
  • MW: 329.202 | Formula: C13H10Cl2N2O2S
  • H donors: 1 H acceptors: 2 LogP: 3.78 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1c(cccc1Cl)/C=N/NS(=O)(=O)c1ccccc1
  • InChi: 1S/C13H10Cl2N2O2S/c14-12-8-4-5-10(13(12)15)9-16-17-20(18,19)11-6-2-1-3-7-11/h1-9,17H/b16-9+
  • InChiKey: JTJVMOCEZVLZOX-CXUHLZMHSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[(2,3-dichlorophenyl)methyleneamino]benzenesulfonamide
  • N-[(2,3-dichlorobenzylidene)amino]benzenesulfonamide
  • NSC623219
  • NCI60_006925
  • AK-968/11110159

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase 0.1584 0.1432 0.1432
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis conserved hypothetical protein 0.113 0.079 0.0115
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.3152 0.3648 0.6456
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Toxoplasma gondii hypothetical protein 0.1093 0.0739 0.9346
Echinococcus granulosus dual 3'5' cyclic AMP and GMP phosphodiesterase 0.1584 0.1432 0.8412
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.1584 0.1432 0.1539
Mycobacterium tuberculosis Two component sensor histidine kinase DevS 0.3791 0.4551 1
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic 0.1776 0.1703 1
Trichomonas vaginalis conserved hypothetical protein 0.113 0.079 0.0115
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539
Toxoplasma gondii hypothetical protein 0.113 0.079 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.2698 0.3006 0.5947
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Leishmania major hypothetical protein, conserved 0.2698 0.3006 1
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Toxoplasma gondii hypothetical protein 0.1093 0.0739 0.9346
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1548 0.1381 0.1424
Echinococcus multilocularis high affinity cAMP specific 3',5' cyclic 0.0858 0.0406 0.2386
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.4282 0.5245 1
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.4282 0.5245 1
Mycobacterium ulcerans two component sensor histidine kinase DevS 0.3791 0.4551 1
Plasmodium vivax hypothetical protein, conserved 0.1093 0.0739 0.5
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase 0.7647 1 1
Trypanosoma brucei GAF domain/TIP41-like family, putative 0.2698 0.3006 1
Trichomonas vaginalis conserved hypothetical protein 0.113 0.079 0.0115
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.3152 0.3648 0.6456
Trypanosoma cruzi GAF domain/TIP41-like family, putative 0.2698 0.3006 1
Plasmodium falciparum GAF domain-related protein, putative 0.1093 0.0739 1
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Echinococcus multilocularis dual 3',5' cyclic AMP and GMP phosphodiesterase 0.1584 0.1432 0.8412
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic 0.1776 0.1703 1
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.4282 0.5245 1
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.1548 0.1381 0.1424
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cGMP-inhibited 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1548 0.1381 0.1424
Trypanosoma cruzi GAF domain/TIP41-like family, putative 0.2698 0.3006 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539
Loa Loa (eye worm) hypothetical protein 0.7647 1 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539
Mycobacterium leprae conserved hypothetical protein 0.1093 0.0739 0.5
Echinococcus granulosus high affinity cAMP specific 3'5' cyclic 0.0858 0.0406 0.2386
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis conserved hypothetical protein 0.4282 0.5245 1
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539
Toxoplasma gondii GAF domain-containing protein 0.1093 0.0739 0.9346
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539
Trichomonas vaginalis cAMP/cGMP cyclic nucleotide phosphodiesterase, putative 0.1584 0.1432 0.1539

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) -4.847 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.399 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.341 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.337 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.26 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.097 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.025 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.